Question Completion with Options:
a. increasing the size of your cohorts.
b. increasing the diversity of your cohorts.
c. increasing the size of your affected cohort.
d. increasing the diversity of your affected cohort.
Answer:
All of the following modifications to the study are likely to allow identification of new variants associated with the disease, EXCEPT
a. increasing the size of your cohorts.
Explanation:
Option A is chosen because increasing the size of the cohorts will be equally divided between the affected and unaffected cohorts since the study discovered that these two classes are roughly the same size. Therefore, new variants of the disease may not likely be identified and isolated unless the other modification options are followed instead of Option A.
the first option is correct (true).
the greater the surface area of an object the greater the buoyant force.
Answer:
The third diagram shows Refraction of waves.
Explanation:
Refraction is a phenomenon, which occurs in a wave when it travels from one medium to another medium, and during Refraction there is slight or greater change in direction of the wave.
hence, the wave will pass through the surface and displaces from its actual path.
that's why the most appropriate diagram showing Refraction is third one ( c ) .
Answer:
Competition is the rivalry between companies selling similar products and services with the goal of achieving revenue, profit, and market share growth. Market competition motivates companies to increase sales volume by utilizing the four components of the marketing mix, also referred to as the four P's.
Explanation:
Drug that demages capsule is used to treat viral infection because Curing a viral infection antibiotics are useless against viral infections. This is because viruses are so simple that they use their host cells to perform their activities for them. So antiviral drugs work differently to antibiotics, by interfering with the viral enzymes instead.
Antiviral drugs are currently only effective against a few viral diseases, such as influenza, herpes, hepatitis B and C and HIV – but research is ongoing. A naturally occurring protein, called interferon (which the body produces to help fight viral infections), can now be produced in the laboratory and is used to treat hepatitis C infections.
